Hyalex Orthopaedics News
Featured
Featured Press
Initial Results of Hyalex Freestyle Knee Implant First-in-Human Clinical Studies to be Presented at the ISAKOS Congress 2025
- News, Press
Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant
- News, Press
Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors
- News, Press
Hyalex Presents at The Engine’s 2020 Tough Tech Summit
- News
Hyalex Named a Finalist in 2020 UMass Lowell M2D2 $200k Challenge
- News
Hyalex Named a MedTech Innovator 2020 Showcase Company
- News
Hyalex Presents at 2020 Orthopaedic Research Society Conference
- News
Hyalex Adds New Funding; Expanding Series A Total to $33MM
- News